INIS
patients
63%
symptoms
37%
receptors
29%
pain
28%
oils
20%
data
19%
comparative evaluations
19%
quality of life
15%
cost
14%
assessments
11%
humans
10%
italy
9%
control
9%
inflammation
8%
sampling
7%
levels
7%
serotonin
7%
clinical trials
7%
reduction
6%
values
6%
correlations
6%
colon
6%
evaluation
6%
economics
6%
brain
5%
nutrients
5%
red peppers
5%
hospitals
5%
screening
5%
reviews
5%
Keyphrases
Irritable Bowel Syndrome
100%
Symptom Severity
17%
Peppermint Oil
17%
Gastrointestinal Diseases
16%
Abdominal Pain
16%
Transient Receptor Potential Vanilloid 1 (TRPV1)
14%
Diary
10%
Rome III
10%
Treatment Effect
9%
Treatment Assessment
9%
Healthy Individuals
9%
Smart Data
9%
Placebo
8%
End of Day
7%
Visceral Hypersensitivity
7%
Life Satisfaction
7%
Red Pepper
7%
Quality of Life
7%
TRPM8
6%
Anxiety Scale
6%
Expression Profile
6%
Rome IV Criteria
6%
Pain Response
5%
Fecal Microbiota
5%
TRP Channels
5%
Small Intestine
5%
Hospital Anxiety
5%
Depression Scale
5%
Smartphone App
5%
Intestinal Release
5%
Medicine and Dentistry
Irritable Bowel Syndrome
66%
Gastrointestinal Distress
13%
Abdominal Pain
12%
Quality of Life
10%
Receptor Potential
10%
Health Care Cost
10%
Ankyrin
8%
Peppermint Oil
7%
Observational Study
6%
Placebo
6%
functional dyspepsia
6%
Vanilloid Receptor 1
5%
Hospital Anxiety and Depression Scale
5%
